Manila Times Business
SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 6, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUE™, a clinically validated probiotic featuring Lactiplantibacillus plantarum LP28, designed to target immune aging, also known as immunosenescence. The company will showcase SYNMUE™ at Probiota Americas 2026, taking place June 8-10 in Vancouver, Canada, whe
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
SBA Announces Agency-Wide Reorganization to Modernize, Drive Operational Efficiency, and Enhance Accountability to Taxpayers
2h ago
SalesCloser Enters Global Hospitality Sector and Announces Engagement with Major North American Hotel
2h ago
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
2h ago
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2h ago